COSMOS Pharmaceutical Corporation (CSMYF)
USD 46.06
(0.0%)
USD 46.06
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 156.8 Billion JPY | 13.14% |
| 2023 | 138.58 Billion JPY | 13.92% |
| 2022 | 121.65 Billion JPY | 8.65% |
| 2021 | 111.96 Billion JPY | 5.74% |
| 2020 | 105.89 Billion JPY | 9.16% |
| 2019 | 97 Billion JPY | 10.78% |
| 2018 | 87.56 Billion JPY | 12.55% |
| 2017 | 77.8 Billion JPY | 14.08% |
| 2016 | 68.2 Billion JPY | 11.82% |
| 2015 | 60.99 Billion JPY | 13.27% |
| 2014 | 53.84 Billion JPY | 16.42% |
| 2013 | 46.25 Billion JPY | 16.64% |
| 2012 | 39.65 Billion JPY | 11.83% |
| 2011 | 35.46 Billion JPY | 9.72% |
| 2010 | 32.32 Billion JPY | 5.71% |
| 2009 | 30.57 Billion JPY | 9.63% |
| 2008 | 27.88 Billion JPY | 13.41% |
| 2007 | 24.59 Billion JPY | 23.72% |
| 2006 | 19.87 Billion JPY | 28.61% |
| 2005 | 15.45 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 FY | 156.8 Billion JPY | 13.14% |
| 2024 Q4 | 40.87 Billion JPY | 5.27% |
| 2024 Q3 | 38.83 Billion JPY | -0.62% |
| 2024 Q1 | 38.02 Billion JPY | 4.32% |
| 2024 Q2 | 39.07 Billion JPY | 2.76% |
| 2023 FY | 138.58 Billion JPY | 13.92% |
| 2023 Q2 | 34.43 Billion JPY | 3.12% |
| 2023 Q3 | 34.31 Billion JPY | -0.35% |
| 2023 Q4 | 36.44 Billion JPY | 6.21% |
| 2023 Q1 | 33.39 Billion JPY | 4.04% |
| 2022 Q3 | 30.34 Billion JPY | 1.88% |
| 2022 FY | 121.65 Billion JPY | 8.65% |
| 2022 Q4 | 32.09 Billion JPY | 5.78% |
| 2022 Q2 | 29.78 Billion JPY | 1.19% |
| 2022 Q1 | 29.43 Billion JPY | 0.98% |
| 2021 Q1 | 27.58 Billion JPY | 1.78% |
| 2021 Q2 | 27.74 Billion JPY | 0.6% |
| 2021 Q4 | 29.14 Billion JPY | 6.04% |
| 2021 Q3 | 27.48 Billion JPY | -0.94% |
| 2021 FY | 111.96 Billion JPY | 5.74% |
| 2020 Q1 | 26.02 Billion JPY | 3.23% |
| 2020 Q4 | 27.09 Billion JPY | 3.54% |
| 2020 FY | 105.89 Billion JPY | 9.16% |
| 2020 Q3 | 26.17 Billion JPY | -1.6% |
| 2020 Q2 | 26.59 Billion JPY | 2.21% |
| 2019 FY | 97 Billion JPY | 10.78% |
| 2019 Q3 | 24.15 Billion JPY | 0.69% |
| 2019 Q4 | 25.2 Billion JPY | 4.38% |
| 2019 Q1 | 23.66 Billion JPY | 4.92% |
| 2019 Q2 | 23.98 Billion JPY | 1.36% |
| 2018 Q2 | 21.79 Billion JPY | 1.66% |
| 2018 FY | 87.56 Billion JPY | 12.55% |
| 2018 Q4 | 22.55 Billion JPY | 3.6% |
| 2018 Q3 | 21.77 Billion JPY | -0.12% |
| 2018 Q1 | 21.44 Billion JPY | 3.36% |
| 2017 Q1 | 18.64 Billion JPY | 3.54% |
| 2017 Q4 | 20.74 Billion JPY | 7.72% |
| 2017 FY | 77.8 Billion JPY | 14.08% |
| 2017 Q2 | 19.15 Billion JPY | 2.77% |
| 2017 Q3 | 19.26 Billion JPY | 0.53% |
| 2016 Q2 | 16.78 Billion JPY | 2.04% |
| 2016 FY | 68.2 Billion JPY | 11.82% |
| 2016 Q3 | 16.96 Billion JPY | 1.1% |
| 2016 Q1 | 16.44 Billion JPY | 3.31% |
| 2016 Q4 | 18 Billion JPY | 6.11% |
| 2015 FY | 60.99 Billion JPY | 13.27% |
| 2015 Q1 | 14.71 Billion JPY | 2.5% |
| 2015 Q2 | 14.91 Billion JPY | 1.39% |
| 2015 Q3 | 15.44 Billion JPY | 3.57% |
| 2015 Q4 | 15.92 Billion JPY | 3.07% |
| 2014 Q1 | 12.99 Billion JPY | 2.61% |
| 2014 FY | 53.84 Billion JPY | 16.42% |
| 2014 Q4 | 14.35 Billion JPY | 9.03% |
| 2014 Q3 | 13.16 Billion JPY | -1.33% |
| 2014 Q2 | 13.33 Billion JPY | 2.63% |
| 2013 Q4 | 12.66 Billion JPY | 10.3% |
| 2013 FY | 46.25 Billion JPY | 16.64% |
| 2013 Q1 | 10.78 Billion JPY | 0.34% |
| 2013 Q2 | 11.31 Billion JPY | 4.9% |
| 2013 Q3 | 11.48 Billion JPY | 1.48% |
| 2012 Q1 | 9.39 Billion JPY | -0.85% |
| 2012 FY | 39.65 Billion JPY | 11.83% |
| 2012 Q3 | 9.83 Billion JPY | 1.59% |
| 2012 Q2 | 9.67 Billion JPY | 3.03% |
| 2012 Q4 | 10.75 Billion JPY | 9.34% |
| 2011 FY | 35.46 Billion JPY | 9.72% |
| 2011 Q4 | 9.47 Billion JPY | 8.87% |
| 2011 Q1 | 8.59 Billion JPY | 4.95% |
| 2011 Q2 | 8.68 Billion JPY | 1.09% |
| 2011 Q3 | 8.7 Billion JPY | 0.17% |
| 2010 Q2 | 8.02 Billion JPY | -1.23% |
| 2010 Q1 | 8.12 Billion JPY | 3.91% |
| 2010 Q4 | 8.18 Billion JPY | 2.58% |
| 2010 FY | 32.32 Billion JPY | 5.71% |
| 2010 Q3 | 7.98 Billion JPY | -0.51% |
| 2009 Q2 | 7.56 Billion JPY | 0.0% |
| 2009 Q4 | 7.81 Billion JPY | 0.94% |
| 2009 FY | 30.57 Billion JPY | 9.63% |
| 2009 Q3 | 7.74 Billion JPY | 2.35% |
| 2008 FY | 27.88 Billion JPY | 13.41% |
| 2007 FY | 24.59 Billion JPY | 23.72% |
| 2006 FY | 19.87 Billion JPY | 28.61% |
| 2005 FY | 15.45 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 3437.19 USD | -4561982216.951% |
| Allstar Health Brands, Inc. | 215.74 Thousand USD | -72679473.76% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 55.24 Million USD | -283750.561% |
| Café Serendipity Holdings, Inc. | 1.43 Million USD | -10917193.861% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 47.57 Thousand USD | -329627816.754% |
| HealthWarehouse.com, Inc. | 13.79 Million USD | -1136523.518% |
| LIGAND PHARMACEUTICAL INC | 78.2 Million USD | -200403.804% |
| MedGen, Inc. | 16.59 USD | -945171790135.081% |
| Omni Health, Inc. | 1.14 Million USD | -13670383.494% |
| Oxford Investments Holdings Inc. | 373.76 Thousand USD | -41952912.754% |
| Pineapple, Inc. | 452.94 Thousand USD | -34618443.409% |
| ScripsAmerica, Inc. | 31.4 Million USD | -499205.941% |